Association of molecular characteristics with survival in advanced non-small cell lung cancer patients treated with checkpoint inhibitors

被引：0
|
作者：
Zhao, Dan [1 ]
Mambetsariev, Isa [1 ]
Li, Haiqing [1 ]
Chen, Chen [1 ]
Fricke, Jeremy [1 ]
Fann, Patricia [1 ]
Kulkarni, Prakash [1 ]
Xing, Yan [1 ]
Lee, Peter [1 ]
Bild, Andrea [1 ]
Massarelli, Erminia [1 ]
Koczywas, Marianna [1 ]
Reckamp, Karen [1 ]
Salgia, Ravi [1 ]
机构：
[1] City Hope Natl Med Ctr, Duarte, CA USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
Lung cancer; molecular; next-generation sequencing (NGS); immune checkpoint inhibitors; TET2; FANCA; PD-L1; TMB; immunotherapy;
D O I：
10.1158/1538-7445.AM2020-3300
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3300
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Association of molecular characteristics with survival in advanced non-small cell lung cancer patients treated with checkpoint inhibitors
    Zhao, Dan
    Mambetsariev, Isa
    Li, Haiqing
    Chen, Chen
    Fricke, Jeremy
    Fann, Patricia
    Kulkarni, Prakash
    Xing, Yan
    Lee, Peter P.
    Bild, Andrea
    Massarelli, Erminia
    Koczywas, Marianna
    Reckamp, Karen
    Salgia, Ravi
    [J]. LUNG CANCER, 2020, 146 : 174 - 181
  • [2] Checkpoint inhibitors in older patients with advanced non-small cell lung cancer
    Reale, Maria Lucia
    Romano, Gianpiero Diego
    Paolelli, Loretta
    Leo, Silvana
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2023, 188
  • [3] Hyperprogressive disease in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors
    Ayala de Miguel, P.
    Lopez Gallego, J.
    Gorospe Garcia, I.
    Illan Varella, A.
    Rivera Vargas, P. R.
    Posada Restrepo, A.
    Borrega Garcia, P.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [4] Patterns of Failure in Patients With Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
    Chai, Rong
    Yin, Yipengchen
    Cai, Xuwei
    Fu, Xiaolong
    Zhang, Qin
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [5] Hyperprogressive Disease in Advanced Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
    Lo Russo, G.
    Signorelli, D.
    Proto, C.
    Galli, G.
    Prelaj, A.
    Ferrara, R.
    Sommariva, M.
    Moro, M.
    Cancila, V.
    Ganzinelli, M.
    Brich, S.
    Sangaletti, S.
    Pruneri, G.
    Tripodo, C.
    Colombo, M. P.
    Rivoltini, L.
    Balsari, A.
    Sozzi, G.
    Boeri, M.
    Garassino, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S245 - S245
  • [6] Restricted mean survival time in advanced non-small cell lung cancer treated with immune checkpoint inhibitors
    Di Spazio, L.
    Cancanelli, L.
    Rivano, M.
    Chiumente, M.
    Mengato, D.
    Messori, A.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (04) : 1881 - 1889
  • [7] Long-term survival of patients with advanced non-small cell lung cancer treated using immune checkpoint inhibitors
    Tamiya, Akihiro
    [J]. RESPIRATORY INVESTIGATION, 2024, 62 (01) : 85 - 89
  • [8] The genomic characteristics of different progression patterns in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors
    Li, Jingwen
    Xiang, Chan
    Wang, Yue
    Zhou, Yan
    Cao, Shuhui
    Ling, Xuxinyi
    Ye, Junyi
    Zheng, Jingjing
    Shao, Lin
    Zhong, Hua
    Han, Yuchen
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (09)
  • [9] Association of baseline characteristics and survival in patients with advanced non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (CPIs): Real-world evidence.
    Crawley, Danielle
    Beckmann, Kerri
    Ravindra, Saranya
    Josephs, Debra Hannah
    Spicer, James F.
    Montes, Ana
    Karapanagiotou, Eleni
    Ghosh, Sharmistha
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] Immune checkpoint inhibitors in advanced non-small cell lung cancer
    Fabre, Elizabeth
    Pecuchet, Nicola
    Cadranel, Jacques
    [J]. BULLETIN DU CANCER, 2016, 103 : S138 - S143
12345